France Aesthetic Medicine Market Size & Outlook, 2026-2033
The aesthetic medicine market in France is expected to reach a projected revenue of US$ 11,661.8 million by 2033. A compound annual growth rate of 15.4% is expected of France aesthetic medicine market from 2025 to 2033.
The France aesthetic medicine market generated a revenue of USD 3,234.6 million in 2024 and is expected to reach USD 11,661.8 million by 2033.
The France market is expected to grow at a CAGR of 15.4% from 2025 to 2033.
In terms of segment, non-invasive procedures was the largest revenue generating type in 2024.
Non-invasive procedures is the most lucrative type segment registering the fastest growth during the forecast period.
Aesthetic medicine market data book summary
Market revenue in 2024
USD 3,234.6 million
Market revenue in 2033
USD 11,661.8 million
Growth rate
15.4% (CAGR from 2025 to 2033)
Largest segment
Non-invasive procedures
Fastest growing segment
Non-invasive procedures
Historical data
2021 - 2023
Base year
2024
Forecast period
2025 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Invasive procedures, Non-invasive procedures
Key market players worldwide
AbbVie Inc, Cynosure, Evolus Inc, Lumenis, Bausch Health Companies Inc, Fosun International Ltd, Revance Therapeutics Inc, Candela Medical
Other key industry trends
In terms of revenue, France accounted for 3.6% of the global aesthetic medicine market in 2024.
Country-wise, Germany is expected to lead the global market in terms of revenue in 2033.
In Europe, Germany aesthetic medicine market is projected to lead the regional market in terms of revenue in 2033.
Germany is the fastest growing regional market in Europe and is projected to reach USD 41,528.5 million by 2033.
According to estimates by export.gov, France is currently the global leader in cosmetic market. It is among the top 10 countries responsible for a large number of cosmetic procedures, accounting for around 2.2% of all procedures performed worldwide.
This can be attributed to high esthetic & fashion consciousness in the country. French products are sold in more than 200 countries and the label “Made in France” is considered a sign of high quality.
Increased awareness among customers about potential benefits of aesthetic procedures coupled with growing adoption of noninvasive procedures is boosting the aesthetic medicine market in France. In addition, noninvasive or minimally invasive techniques have gained popularity.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aesthetic Medicine Market Outlook will help companies and investors design strategic landscapes.
Non-Invasive Procedures was the largest segment with a revenue share of 76.4% in 2024.
Horizon Databook has segmented the France aesthetic medicine market based on invasive procedures, non-invasive procedures covering the revenue growth of each sub-segment from 2021 to 2033.
According to estimates by export.gov, France is currently the global leader in cosmetic market. It is among the top 10 countries responsible for a large number of cosmetic procedures, accounting for around 2.2% of all procedures performed worldwide.
This can be attributed to high esthetic & fashion consciousness in the country. French products are sold in more than 200 countries and the label “Made in France” is considered a sign of high quality.
Increased awareness among customers about potential benefits of aesthetic procedures coupled with growing adoption of noninvasive procedures is boosting the aesthetic medicine market in France. In addition, noninvasive or minimally invasive techniques have gained popularity.
France Aesthetic Medicine Market Type Outlook (Revenue, USD Million , 2021-2033)
Invasive procedures
Non-invasive procedures
France Aesthetic Medicine Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Clinics & Aesthetic Centers
Medspas
Reasons to subscribe to Aesthetic Medicine Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aesthetic Medicine Market Outlook databook
Our clientele includes a mix of Aesthetic Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France Aesthetic Medicine Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France Aesthetic Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
France Aesthetic Medicine Market, 2021-2033 (US$M)